Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: AIDS. 2021 Jan 1;35(1):131–139. doi: 10.1097/QAD.0000000000002728

Table 2.

Among 722 Keeping it LITE participants who heard of the Truvada lawsuit, characteristics of information dissemination and effect of lawsuit.

Heard about lawsuit N (%)
How did you hear about the lawsuit?
 Word of mouth 324 (46.0)
 Billboards 61 (8.7)
 Print Media 205 (29.1)
 Radio/TV Media 218 (31.0)
 Social Media 623 (88.5)
 Mobile Media 226 (32.1)
 Other 36 (5.1)
Heard about the lawsuit from more than one source?a 511 (70.8)
Did the advertisements change your decision to start Truvada-based PrEP or stop taking Truvada-based PrEP?
 No, Truvada was never an option 92 (13.1)
 No, I never considered starting Truvada 200 (28.4)
 No, I decided to continue taking Truvada 280 (39.8)
 Yes, I decided against starting Truvada 93 (13.2)
 Yes, I decided to quit taking Truvada 39 (5.5)
Did hearing about the lawsuit change your opinion about Truvada-based PrEP? (Yes). 226 (32.1)
Major Themes from Qualitative Analysis:
1) Respondents discussed concern about risks / benefits of using Truvada 91 (40.26)
2) Respondents discussed concern about possible side effects 91 (40.27)
3) Respondents discussed interest for other biomedical (Descovy) and/or other behavioral prevention interventions 20 (8.85)
4) Respondents discussed distrust of pharmaceutical industry / viewing the industry as greedy 24 (10.62)
a

This figure summed how many participants heard about the lawsuit from more than one source.